Profile
Robert L.
Roe served as President & CEO of Allergenics, Inc. from 1999 to 2001, President-Development Research Division & SVP of Syntex Corp.
from 1992 to 1995, Chief Operating Officer & EVP of Cytel Corp.
from 1996 to 1999, and President & Secretary of Corcept Therapeutics, Inc. from 2001 to 2013.
He also served as a Director at Aerogen, Inc., Talima Therapeutics, Inc., and VitreoRetinal Technologies, Inc. Additionally, Roe received an undergraduate degree from Stanford University and a doctorate from The University of California, San Francisco.
Former positions of Robert L. Roe
| Companies | Position | End |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | President | 30/12/2013 |
| Allergenics, Inc. | President | 31/12/2000 |
| Cytel Corp. | Chief Operating Officer | 31/12/1998 |
Chugai Biopharmaceuticals, Inc.
 Chugai Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Chugai Biopharmaceuticals, Inc. manufactures pharmaceuticals products. It offers vitamin and mineral supplements, herbal formulations, health & beauty products, creams, ointments, effervescent tablets, and veterinary products. The company was founded in 1995 and is headquartered in San Diego, CA. | Chief Operating Officer | 31/12/1995 |
| Syntex Corp. | Corporate Officer/Principal | 31/12/1994 |
Training of Robert L. Roe
| Stanford University | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| Private companies | 7 |
|---|---|
| Syntex Corp. | Health Technology |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Health Technology |
Talima Therapeutics, Inc.
 Talima Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talima Therapeutics, Inc. operated as a drug delivery company. It had developed a micro implant delivery technology for the localized application of small molecule drugs. The firm’s product was in phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the toenails. The company was founded in 2004 and was headquartered in San Carlos, CA. | Health Technology |
VitreoRetinal Technologies, Inc.
 VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Health Technology |
| Cytel Corp. | |
| Allergenics, Inc. | |
Chugai Biopharmaceuticals, Inc.
Chugai Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Chugai Biopharmaceuticals, Inc. manufactures pharmaceuticals products. It offers vitamin and mineral supplements, herbal formulations, health & beauty products, creams, ointments, effervescent tablets, and veterinary products. The company was founded in 1995 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Robert L. Roe
